Compounds > quinoxalines
Page last updated: 2024-08-17

quinoxalines and Carcinoma, Medullary

quinoxalines has been researched along with Carcinoma, Medullary in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Durham, PL; Russo, AF1

Other Studies

1 other study(ies) available for quinoxalines and Carcinoma, Medullary

ArticleYear
Serotonergic repression of mitogen-activated protein kinase control of the calcitonin gene-related peptide enhancer.
    Molecular endocrinology (Baltimore, Md.), 1998, Volume: 12, Issue:7

    Topics: Animals; Calcitonin Gene-Related Peptide; Calcium-Calmodulin-Dependent Protein Kinases; Carcinoma, Medullary; Cell Cycle Proteins; DNA-Binding Proteins; Dual Specificity Phosphatase 1; Enhancer Elements, Genetic; ets-Domain Protein Elk-1; Genes, jun; Immediate-Early Proteins; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinase Kinases; Mitogen-Activated Protein Kinases; Phosphoprotein Phosphatases; Phosphorylation; Protein Kinases; Protein Phosphatase 1; Protein Tyrosine Phosphatase, Non-Receptor Type 1; Protein Tyrosine Phosphatases; Proto-Oncogene Proteins; Quinoxalines; Rats; Serotonin; Serotonin Receptor Agonists; Thyroid Neoplasms; Transcription Factors; Transfection; Tumor Cells, Cultured

1998